Attila Németh

Title: Attila Németh: Innovator in Biotechnology

Introduction

Attila Németh is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of biotechnology, particularly in the synthesis of cannabinoids and the development of novel cell membrane preparations. With a total of 2 patents, Németh's work is paving the way for advancements in various applications.

Latest Patents

Németh's latest patents include groundbreaking inventions related to microorganisms and methods for the fermentation of cannabinoids. These inventions disclose microorganisms and methods that can be utilized for the synthesis of cannabigerolic acid (CBGA) and various cannabinoids. The methods can produce CBGA, Δ-tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), cannabichromenic acid (CBCA), Δ-tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabichromene (CBC). The enzymes useful for this synthesis include acyl activating enzyme (AAE1), polyketide synthase (PKS), and several others. Additionally, he has developed a cholesterol-loaded insect cell membrane preparation that enhances substrate transport activity due to increased cholesterol levels. This invention also includes reagent kits and methods for measuring the activity of ABC transporters present in these membranes.

Career Highlights

Throughout his career, Attila Németh has worked with notable companies such as Solvo Biotechnológiai Zrt. and Eleszto Genetika, Inc. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to advancements that have the potential to impact various industries.

Collaborations

Németh has collaborated with esteemed colleagues, including György Báthori and Dóra Méhn. These partnerships have further enriched his research and development efforts, leading to significant breakthroughs in his field.

Conclusion

Attila Németh is a distinguished inventor whose contributions to biotechnology are noteworthy. His patents and collaborative efforts reflect a commitment to innovation and advancement in the synthesis of cannabinoids and cell membrane technology. His work continues to inspire future developments in the industry.